Topper David Joseph, CFO of Arcutis Biotherapeutics ($ARQT), made one open market sale of company shares in the last year, totaling about $152,000, with the most recent on April 2, 2025. His sales volume ranks 8,963rd among 11,678 insiders, well below the average of 8.6 million per seller and 6.4 transactions. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Topper David Joseph | Chief Financial Officer | S | Common Stock | 9600 | $15.80 | 182,774.0000 | 120,957,633 | 4.99% | 0.01% |
| Feb. 28, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Topper David Joseph | Chief Financial Officer | A | Common Stock | 34000 | $0.00 | 192,374.0000 | 120,957,633 | 21.47% | 0.03% |
| Feb. 28, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Topper David Joseph | Chief Financial Officer | A | Stock Option (right to buy) | 89000 | $0.00 | 89,000.0000 | 120,957,633 | 9999.99% | 0.07% |
| Sept. 21, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Topper David Joseph | Chief Financial Officer | A | Common Stock | 60000 | $0.00 | 170,000.0000 | 69,305,487 | 54.55% | 0.09% |
| Sept. 24, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Topper David Joseph | Chief Financial Officer | S | Common Stock | 11626 | $9.48 | 158,374.0000 | 69,305,487 | 6.84% | 0.02% |
| April 10, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Topper David Joseph | Chief Financial Officer | A | Common Stock | 110000 | $0.00 | 110,000.0000 | 69,305,487 | 9999.99% | 0.16% |
| April 10, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Topper David Joseph | Chief Financial Officer | A | Stock Option (right to buy) | 310000 | $0.00 | 310,000.0000 | 69,305,487 | 9999.99% | 0.45% |